BRUKER CORPORATION Payments for Repurchase of Common Stock
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- BRUKER CORPORATION payments for repurchase of common stock for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- BRUKER CORPORATION payments for repurchase of common stock for the quarter ending 2025-12-31 was $0.00.
- BRUKER CORPORATION payments for repurchase of common stock for the quarter ending 2025-09-30 was $0.00.
- BRUKER CORPORATION payments for repurchase of common stock for the quarter ending 2025-06-30 was $0.00.
- BRUKER CORPORATION payments for repurchase of common stock for fiscal 2025 was $10.00M.
- BRUKER CORPORATION payments for repurchase of common stock for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- BRUKER CORPORATION payments for repurchase of common stock for fiscal 2023 was $152.30M, a 42.11% decline from fiscal 2022.
- BRUKER CORPORATION payments for repurchase of common stock for fiscal 2022 was $263.10M, a 71.62% increase from fiscal 2021.
| Period end | Payments for Repurchase of Common Stock 3 month | Payments for Repurchase of Common Stock 12 month |
|---|---|---|
| 2026-03-31 | $0.00 10-Q · filed 2026-05-07 | $0.00 derived: sum of 4 quarters · filed 2026-05-07 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $10.00M 10-K · filed 2026-02-27 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $10.00M derived: sum of 4 quarters · filed 2026-05-07 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $10.00M derived: sum of 4 quarters · filed 2026-05-07 |
| 2025-03-31 | $10.00M 10-Q · filed 2026-05-07 | $10.00M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $0.00 10-K · filed 2026-02-27 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $50.40M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $129.90M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-07 | $129.90M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $50.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $152.30M 10-K · filed 2026-02-27 |
| 2023-09-30 | $79.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $128.20M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $119.60M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-03-31 | $22.40M 10-Q · filed 2024-05-10 | $179.90M derived: sum of 4 quarters · filed 2025-03-03 |
| 2022-12-31 | $26.30M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $263.10M 10-K · filed 2025-03-03 |
| 2022-09-30 | $70.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $319.00M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $60.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $248.10M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $105.60M 10-Q · filed 2023-05-10 | $226.30M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $82.20M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $153.30M 10-K · filed 2024-02-29 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $139.90M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $38.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $144.30M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $32.60M 10-Q · filed 2022-05-06 | |
| 2020-12-31 | $68.80M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $123.20M 10-K · filed 2023-03-01 |
| 2020-09-30 | $4.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $142.30M 10-K · filed 2022-02-28 |
| 2019-09-30 | $42.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | |
| 2017-12-31 | $22.50M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | $152.20M 10-K · filed 2020-03-27 |
| 2017-09-30 | $88.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | |
| 2016-12-31 | $16.50M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $160.00M 10-K · filed 2019-03-01 |
| 2016-09-30 | $25.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $208.60M derived: sum of 4 quarters · filed 2018-03-16 |
| 2016-06-30 | $38.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $190.40M derived: sum of 4 quarters · filed 2018-03-16 |
| 2016-03-31 | $78.90M 10-Q · filed 2017-05-10 | |
| 2015-12-31 | $65.10M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $90.00M 10-K · filed 2018-03-16 |
| 2015-09-30 | $7.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |